Details

Dynamics of leukocyte telomere length in patients with Fabry disease
ID Levstek, Tina (Author), ID Breznik, Nika (Author), ID Vujkovac, Bojan (Author), ID Nowak, Albina (Author), ID Trebušak Podkrajšek, Katarina (Author)

.pdfPDF - Presentation file, Download (731,45 KB)
MD5: A759E4D57021AA05463423E5FC00CA8F
URLURL - Source URL, Visit https://www.mdpi.com/2227-9059/12/8/1724 This link opens in a new window

Abstract
Fabry disease (FD) leads to significant morbidity and mortality, which may indicate accelerated ageing. However, it is still unclear whether there is a relationship between telomere length (TL), a marker of biological ageing, and disease outcome. We aimed to examine the relationship between leukocyte TL (LTL) dynamics and the presence of advanced disease stages and/or late complications of FD, including hypertrophic cardiomyopathy, nephropathy and stroke, both cross-sectionally and longitudinally. DNA was extracted from peripheral blood leukocytes and quantitative PCR was utilized to determine relative LTL in 99 Fabry patients. In the longitudinal analysis, we included 50 patients in whom at least three measurements were performed over a period of 5–10 years. The results showed a significant inverse correlation between LTL and age (ρ = −0.20, p = 0.05). No significant differences in LTL were found between females and males (p = 0.79) or between patients receiving disease-specific therapy and those without (p = 0.34). In a cross-sectional analysis, no association was found between the presence (p = 0.15) or number (p = 0.28) of advanced stages of the disease and/or late complications and LTL. Similarly, in a longitudinal analysis, no difference in LTL dynamics was found regarding the presence (p = 0.16) of advanced stage organ involvement and/or late complications or their number. These findings indicate that LTL dynamics in adulthood may not be a reliable indicator of disease outcomes in Fabry patients. Therefore, LTL may more accurately reflect the disease burden in early life, when TL is primarily determined.

Language:English
Keywords:Fabry disease, telomere length, hyperthropic cardiomyopathy, nephropathy, stroke
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:9 str.
Numbering:Vol. 12, iss. 8, art. 1724
PID:20.500.12556/RUL-166796 This link opens in a new window
UDC:616-07
ISSN on article:2227-9059
DOI:10.3390/biomedicines12081724 This link opens in a new window
COBISS.SI-ID:203575043 This link opens in a new window
Publication date in RUL:24.01.2025
Views:223
Downloads:95
Metadata:XML DC-XML DC-RDF
:
LEVSTEK, Tina, BREZNIK, Nika, VUJKOVAC, Bojan, NOWAK, Albina and TREBUŠAK PODKRAJŠEK, Katarina, 2024, Dynamics of leukocyte telomere length in patients with Fabry disease. Biomedicines [online]. 2024. Vol. 12, no. 8,  1724. [Accessed 12 April 2025]. DOI 10.3390/biomedicines12081724. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=166796
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Biomedicines
Shortened title:Biomedicines
Publisher:MDPI AG
ISSN:2227-9059
COBISS.SI-ID:523006745 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:Fabrijeva bolezen, dolžina telomer, hipertrofična kardiomiopatija, nefropatija, kap

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0170
Name:Molekulski mehanizmi uravnavanja celičnih procesov v povezavi z nekaterimi boleznimi pri človeku

Funder:ARRS - Slovenian Research Agency
Project number:J3-50113
Name:Prepoznavanje in longitudinalna opredelitev bioloških označevalcev razvoja in napredovanja nefropatije pri Fabryjevi bolezni

Funder:Other - Other funder or multiple funders
Funding programme:Takeda Pharmaceuticals

Funder:Other - Other funder or multiple funders
Funding programme:University Foundation of ing. Lenarčič Milan

Similar documents

Similar works from RUL:
  1. Evropska konvencija in njen pomen
  2. Strategija in preoblikovanje carinske službe RS v luči vključevanja Slovenije v Evropsko unijo
  3. Vpliv širitev Evropske unije na izgradnjo evropske idntitete
  4. Učinkovitost izravnalnih ukrepov po Schengenski konvenciji v Republiki Sloveniji
  5. Vloga nosilcev izvršne oblasti in parlamentov držav članic EU v primerjavi s Slovenijo
Similar works from other Slovenian collections:
  1. Vloga znotrajžilnih posegov intervencijske onkologije pri vodenju bolnikov z jetrnimi zasevki raka debelega črevesja in danke
  2. Obravnava dednega raka debelega črevesa in danke
  3. Odkrivanje in preprečevanje zgodnjih oblik raka debelega črevesa in danke
  4. Factors for effective colorectal cancer screening
  5. Diagnostični algoritmi raka debelega črevesa in danke

Back